NAOS recently attended the 36th Annual Canaccord Growth Conference in Boston where over 300 predominately US based companies presented. As the title suggests this conference is all about growth companies hence there was a strong presence of both biotechnology and technology companies presenting to investors. NAOS does not place an investment emphasis on the biotechnology due to the higher risk profile so we chose to pay attention to the technology companies. In the article below, we’ve summarised a few key themes which were consistently repeated throughout the conference.